text_1: Several lines of evidence suggest that the known principal RB pathway lesions in human tumors act in a mutual exclusive manner.
text_2: In individual human tumor specimens, these principal components of the pathway—RB-CDK4/6-p16INK4A—are reported to be targeted in a mutually exclusive manner.